Advertisement
Journal Home
Search for

Volume 81, Issue 2, Pages 140-142 (February 2010)


View previous. 12 of 24 View next.

Assessment of a disposable trocar for insertion of contraceptive implants

Markus J. SteineraCorresponding Author Informationemail address, Tania Bolerb, George Obhaib, David Hubachera

Received 22 July 2009; received in revised form 13 August 2009; accepted 19 August 2009. published online 05 October 2009.

Abstract 

Background

Reusable stainless steel trocars have traditionally been used to insert levonorgestrel-releasing contraceptive implants, yet they are cumbersome to maintain because of sterilization requirements. In addition, sterilization equipment is not always available in many settings and inadequate cleaning could lead to HIV transmission.

Study Design

A new disposable trocar for two-rod implants [i.e., Sino-implant (II) and Jadelle] was compared to a traditional reusable two-rod trocar. Clinicians in Kenya assessed the trocars in terms of ease of use, malfunctions and adverse events.

Results

Eighty insertions were done with the new disposable trocar and 80 insertions were done with the traditional reusable trocar; no differences in performance were found. The disposable trocar was easy to use, did not malfunction and did not cause adverse patient events. These clinical data, combined with the review of the product technical file and an inspection of the manufacturing facility by a Norwegian certification body (Det Norske Veritas), resulted in obtaining the CE Mark, a mandatory conformity mark for the distribution of this medical device in European Union member states.

Conclusions

Disposable trocars eliminate the need for sterilization; this will facilitate provision of contraceptive implants in resource-constrained settings and may decrease the risk of HIV transmission. Combined with recent reduction in prices of implants, these new developments should increase access to this important contraceptive technology in many parts of the world.

a Family Health International, PO Box 13950, Research Triangle Park, NC 27709, USA

b Marie Stopes International, London W1T 6LP, UK

Corresponding Author InformationCorresponding author. Tel.: +1 919 544 7040x11346; fax: +1 919 544 7261.

 Support for this research was provided by the Bill & Melinda Gates Foundation. The views expressed in this publication do not necessarily reflect those of Family Health International, Marie Stopes International or the funding agency.

PII: S0010-7824(09)00385-0

doi:10.1016/j.contraception.2009.08.006


View previous. 12 of 24 View next.

Advertisement